Team

Jennifer R. Cochran, PhD
Executive Chair, Co-founder

Widya Mulyasasmita, PhD
Chief Business Officer

Bob Chen, PhD
Director of Engineering, Co-founder

Vivian Hsieh, PhD
Assay Development

Monica Moreno, PhD

Immunology

Ryan Kelly, PhD
Antibody Discovery

Carlos Rodriguez

Antibody Discovery

Cheryl Chang

Molecular Biology

Sam Hatch

Screening & Sequencing

Miguel Palermo

Immunology

Mimi Enea

Administration

Advisors

K. Dane Wittrup, PhD

Co-founder, C.P. Dubbs Professor of Chemical Engineering and Biological Engineering at MIT

James A. Wells, PhD

Harry W. and Diana V. Hind Distinguished Professor in Pharmaceutical Sciences at UCSF

Antoni Ribas, MD PhD

Professor of Medicine, of  Surgery, and of Molecular and Medical Pharmacology, UCLA

Ronald Levy, MD

Robert K. and Helen K. Summy Professor, Stanford Medicine- Oncology

Dean Sheppard, MD

Professor of Medicine, UCSF; Founding Director, UCSF Lung Biology Center

Fran Heller, JD

CEO and founder of Good2Go

Board of Directors

Jennifer R. Cochran, PhD
Executive Chair, Co-founder

Darius Kharabi, JD, MBA

Chief Operating Officer of Lagunita Biosciences

Mark S. Blumenkranz, MD

Chairman of Lagunita Biosciences

Kenneth A. Clark, JD

Partner, Wilson Sonsini Goodrich & Rosati

Steven D. Schwartz, MD

Phone:      (650) 461 - 4503

Email:        info@xcellabio.com

1490 O’Brien Drive, Suite C

Menlo Park, CA 94025